Resolving the onset of antidepressants' clinical actions: Critical for clinical practice and new drug development

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 549-553

  Katz, Martin M ^a,c   Bowden, Charles L ^a   Berman, Nancy ^b   Frazer, Alan ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; DESIPRAMINE; IMIPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; COGNITION; DEPRESSION; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HAMILTON SCALE; HUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION PROCESS;

AFFECT; ANIMALS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSION; DESIPRAMINE; DRUG DESIGN; HOSTILITY; HUMANS; MOTOR ACTIVITY; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751073678     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000246220.04422.de     Document Type: Editorial

References (19)

1. Schatzberg AF, Cole JO, DeBattista C, et al. Antidepressants, Manual of Clinical Psychopharmacology. 4th ed. Washington, DC: American Psychiatric Publishing; 2003:37-157.
2. Fixing the drug pipeline. Economist. 2004;370:37-38.
3. Quitkin FM, Rabkin JG, Ross D, et al. Identification of true drug response to antidepressants. Arch Gen Psychiatry. 1984;41:782-786.
4. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
5. Katz MM, Tekell JL, Bowden CL, et al. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology. 2004;29:566-579.
6. Coryell W, Coppen A, Zeigler VE, et al. Early improvement as a predictor of response to amitriptyline and nortriptyline: a comparison of two patient samples. Psychol Med. 1982;12:135-139.
7. Szegedi A, Muller MJ, Anghelescu I, et al. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high selectivity in patients with major depression. J Clin Psychiatry. 2003;64:413-420.
8. Katz MM, Koslow SH, Maas JW, et al. Identifying the specific clinical actions of amitriptyline: interrelationships of behavior, affect, and plasma levels in depression. Psychol Med. 1991;21:599-611.
9. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry. 1990;47:411-418.
10. Morilak D, Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioral effects in depression and anxiety disorders. Int J Neuropsychopharmacol. 2004;7:193-218.
11. Nelson JC. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of depression. Biol Psychiatry. 1999;46:1301-1302.
12. Mitchell AJ. Two week delay in onset of action of antidepressants: new evidence. Br J Psychiatry. 2006;188:105-106.
13. Papakostas GI, Perlis RH, Scalia MJ, et al. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol. 2006;26:56-60.
14. Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry. 2005;66:148-155.
15. Stassen HH, Angst J, Delini-Stula A. Delayed onset of action of antidepressant drugs: fact or fiction? CNS Drugs. 1998;13:177-184.
16. Laird NM, Ware JH. Random effects model for longitudinal data. Biometrics. 1982;38:963-974.
17. Stassen HH, Delini-Stula A, Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol. 1993;3:127-135.
18. Katz MM, Houston JP, Brannan S, et al. A multivantaged behavioral method for measuring onset and sequence of the clinical actions of antidepressants. Int J Neuropsychopharmacol. 2004;7:471-479.
19. Raskin A, Schulterbrandt JG, Reatig N, et al. Replication of factors of psychopathology in interview, ward behavior, and self-ratings of hospitalized depressives. J Nerv Ment Dis. 1969;148:87-98.